Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Hikma Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Hikma Ventures

Hikma Ventures

Operating

Hikma Ventures: A global venture capital firm strategically investing in healthcare companies.

Location
London, Greater London, GB
Founded
2015
Firm
Compare
Portfolio
Employees
Website

Hikma Ventures is a global venture capital firm focused on strategic investments in healthcare companies. The firm primarily targets digital health and life sciences startups, with a particular emphasis on Series A and B funding rounds. Hikma Ventures leverages its parent company's expertise and global presence to accelerate revenue growth and enhance value creation for its portfolio companies.

Notable investments include Activ Surgical, Biolinq, Click Therapeutics, and Octave Bioscience. Led by Managing Director Lana Ghanem, Hikma Ventures aims to broaden Hikma's offerings and tap into emerging opportunities in the healthcare space. The firm's investment philosophy centers on empowering the future of healthcare and unlocking value through strategic partnerships and industry expertise.

Hikma Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments10
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Series B4 (40.0%)
Series A3 (30.0%)
Seed1 (10.0%)
Series C1 (10.0%)
Series Unknown1 (10.0%)

Stage Mix

Series B 40%Series A 30%Seed 10%Series C 10%Series Unknown 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Octave Bioscience logo

Octave Bioscience

Prognos Health logo

Prognos Health

Activ Surgical logo

Activ Surgical

BioSapien logo

BioSapien

Biolinq logo

Biolinq

Click Therapeutics logo

Click Therapeutics

Hikma Ventures - Similar Investment Firms

Healthcare Ventures logo

Healthcare Ventures

hcven.com

InHealth Ventures logo

InHealth Ventures

inhealth.vc

KHP Ventures logo

KHP Ventures

khpventures.com

LifeLink Ventures logo

LifeLink Ventures

Kima Ventures logo

Kima Ventures

kimaventures.com

Voxel Ventures logo

Voxel Ventures

Global Health Impact Fund logo

Global Health Impact Fund

Inbio Ventures logo

Inbio Ventures

Hike Ventures logo

Hike Ventures

hikevc.com

Intuitive Ventures logo

Intuitive Ventures

Hitachi Ventures logo

Hitachi Ventures

Merlin Ventures logo

Merlin Ventures

merlin.vc

HBM Healthcare Investments logo

HBM Healthcare Investments

hbmhealthcare.com

GT Healthcare Capital Partners logo

GT Healthcare Capital Partners

NextGen Ventures logo

NextGen Ventures

nextgenventures.nl

Hikma Ventures - Classification

Also Known As
  • Hikma Ventures Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end